Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Mr. Cooper Group Inc.

89.8% sales growth and 28.09% return on equity

Mr. Cooper Group Inc. sales growth this year is anticipated to be 31% and 4% for next year.

Year-on-year quarterly revenue growth grew by 41.1%, now sitting on 2.52B for the twelve trailing months.

Mr. Cooper Group Inc.’s sales growth for the next quarter is 89.8%. The company’s growth estimates for the present quarter and the next is 122.3% and 68.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.09%.

Mr. Cooper Group Inc.’s Stock Top and Bottom Yearly Value

Mr. Cooper Group Inc.’s stock is valued at $27.49 at 13:22 EST, below its 52-week high of $28.10 and way above its 52-week low of $4.31.

Mr. Cooper Group Inc.’s Moving Average

Mr. Cooper Group Inc.’s worth is way higher than its 50-day moving average of $24.98 and way above its 200-day moving average of $19.18.

2. Randgold

28.1% sales growth and 14.43% return on equity

Randgold sales growth this year is expected to be 28.7% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 32.2%, now sitting on 12.2B for the twelve trailing months.

Randgold’s sales growth for the next quarter is 28.1%. The company’s growth estimates for the ongoing quarter and the next is 105.9% and 131.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.43%.

Randgold’s Stock Top and Bottom Yearly Value

Randgold’s stock is valued at $22.77 at 13:22 EST, way under its 52-week high of $31.22 and way higher than its 52-week low of $12.65.

Randgold’s Moving Average

Randgold’s value is under its 50-day moving average of $25.05 and way below its 200-day moving average of $26.88.

3. StoneCo Ltd.

48.3% sales growth and 7.86% return on equity

StoneCo Ltd. sales growth this year is anticipated to be 36.7% and 52.4% for next year.

Year-on-year quarterly revenue growth grew by 55%, now sitting on N/A for the twelve trailing months.

StoneCo Ltd.’s sales growth for the next quarter is 48.3%. The company’s growth estimates for the current quarter and the next is 38.9% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.86%.

StoneCo Ltd.’s Stock Top and Bottom Yearly Value

StoneCo Ltd.’s stock is valued at $74.26 at 13:22 EST, below its 52-week high of $74.93 and way higher than its 52-week low of $17.72.

StoneCo Ltd.’s Moving Average

StoneCo Ltd.’s worth is way higher than its 50-day moving average of $64.40 and way higher than its 200-day moving average of $50.73.

4. DAQO New Energy Corp.

42.4% sales growth and 12.84% return on equity

DAQO New Energy Corp. sales growth this year is anticipated to be 91% and 24.5% for next year.

Year-on-year quarterly revenue growth grew by 49.6%, now sitting on 546.8M for the twelve trailing months.

DAQO New Energy Corp.’s sales growth for the next quarter is 42.4%. The company’s growth estimates for the ongoing quarter and the next is 226.5% and 75.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.84%.

DAQO New Energy Corp.’s Stock Top and Bottom Yearly Value

DAQO New Energy Corp.’s stock is valued at $42.22 at 13:22 EST, way below its 52-week high of $48.73 and way above its 52-week low of $8.32.

DAQO New Energy Corp.’s Moving Average

DAQO New Energy Corp.’s worth is higher than its 50-day moving average of $40.65 and way above its 200-day moving average of $26.59.

5. QCR Holdings, Inc.

10.6% sales growth and 10.66% return on equity

QCR Holdings, Inc. sales growth this year is expected to be 12.8% and 1% for next year.

Year-on-year quarterly revenue growth grew by 5.3%, now sitting on 208.6M for the twelve trailing months.

QCR Holdings, Inc.’s sales growth for the next quarter is 10.6%. The company’s growth estimates for the present quarter and the next is a negative 8.9% and 27.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.66%.

QCR Holdings, Inc.’s Stock Top and Bottom Yearly Value

QCR Holdings, Inc.’s stock is valued at $39.06 at 13:22 EST, way under its 52-week high of $44.76 and way higher than its 52-week low of $22.39.

QCR Holdings, Inc.’s Moving Average

QCR Holdings, Inc.’s worth is higher than its 50-day moving average of $35.60 and way higher than its 200-day moving average of $31.28.

6. Molina Healthcare Inc

25.4% sales growth and 40.03% return on equity

Molina Healthcare Inc sales growth this year is expected to be 16.1% and 17.5% for next year.

Year-on-year quarterly revenue growth grew by 16%, now sitting on 17.66B for the twelve trailing months.

Molina Healthcare Inc’s sales growth for the next quarter is 25.4%. The company’s growth estimates for the present quarter and the next is a negative 45.4% and 23.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.03%.

Molina Healthcare Inc’s Stock Top and Bottom Yearly Value

Molina Healthcare Inc’s stock is valued at $200.24 at 13:22 EST, way below its 52-week high of $224.00 and way higher than its 52-week low of $102.85.

Molina Healthcare Inc’s Moving Average

Molina Healthcare Inc’s value is below its 50-day moving average of $208.96 and above its 200-day moving average of $189.77.

7. Calix, Inc

19.5% sales growth and 5.02% return on equity

Calix, Inc sales growth this year is anticipated to be 25.1% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 31.5%, now sitting on 491.4M for the twelve trailing months.

Calix, Inc’s sales growth for the next quarter is 19.5%. The company’s growth estimates for the ongoing quarter and the next is 266.7% and 325%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.

Calix, Inc’s Stock Top and Bottom Yearly Value

Calix, Inc’s stock is valued at $23.83 at 13:22 EST, way below its 52-week high of $27.78 and way higher than its 52-week low of $5.61.

Calix, Inc’s Moving Average

Calix, Inc’s worth is under its 50-day moving average of $24.30 and way above its 200-day moving average of $19.43.

8. BioLife Solutions, Inc.

29.5% sales growth and 5.9% return on equity

BioLife Solutions, Inc. sales growth this year is expected to be 71.2% and 48.2% for next year.

Year-on-year quarterly revenue growth grew by 70.8%, now sitting on 41.66M for the twelve trailing months.

BioLife Solutions, Inc.’s sales growth for the next quarter is 29.5%. The company’s growth estimates for the ongoing quarter and the next is a negative 200% and negative -100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.9%.

BioLife Solutions, Inc.’s Stock Top and Bottom Yearly Value

BioLife Solutions, Inc.’s stock is valued at $40.58 at 13:22 EST, under its 52-week high of $41.39 and way higher than its 52-week low of $7.37.

BioLife Solutions, Inc.’s Moving Average

BioLife Solutions, Inc.’s value is way higher than its 50-day moving average of $33.43 and way above its 200-day moving average of $24.32.

LEAVE A REPLY

Please enter your comment!
Please enter your name here